CIKRIKCIOGLU, M. A.OZDEMIR, A. A.SEKIN, Y.YALCIN, BURAKALTAY, M.GUNDOGDU, A.Erkal, S. N.Kazancioglu, RÜMEYZAERKOC, R.2019-10-052019-10-052015-09-01CIKRIKCIOGLU M. A. , OZDEMIR A. A. , SEKIN Y., YALCIN B., ALTAY M., GUNDOGDU A., Erkal S. N. , Kazancioglu R., ERKOC R., -Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients-, MINERVA UROLOGICA E NEFROLOGICA, cilt.67, ss.187-196, 2015https://hdl.handle.net/20.500.12645/7942Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.enArticleWOS:0003638304000038502184977226197790